I have a terminal illness called cystic fibrosis. Here's why I don't have time for the Left's health care plans.

Detailed price information for Amicus Therapeutics (FOLD-Q) from The Globe and Mail including charting and trades.

Krystal Biotech is upgraded to Strong Buy as Vyjuvek sales surge and catalysts build. Click here to know more.

Preliminary 4Q 2025 VYJUVEK net revenue of $106 million to $107 millionRobust clinical pipeline with multibillion dollar opportunities and strong ...

In this week's Business Digest, staff promotions are announced for a local firm while a local hospital system is welcoming ...

VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, ...

Vitamin C is essential for immunity, energy, and overall health—but how much do you actually need, and when is ...

Brits could be eligible for a financial boost this year from the Department for Work and Pensions (DWP). The DWP has released ...

Because DWP payments are usually made every four weeks, it means retirees can get either £295.60 or £441.60 per payment cycle ...

The Department for Work and Pensions ( DWP) lists 178 medical conditions that could make you eligible for a regular support ...

Many clinical trials include a placebo group—participants who receive an inactive treatment—so researchers can compare ...

CEO and President Joe Payne outlined the company’s current focus on messenger RNA (mRNA) therapeutics, emphasizing a leaner ...